<VariationArchive VariationID="2699" VariationName="NM_033087.4(ALG2):c.1040del (p.Gly347fs)" VariationType="Deletion" Accession="VCV000002699" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2015-02-24" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17738" VariationID="2699">
      <GeneList>
        <Gene Symbol="ALG2" FullName="ALG2 alpha-1,3/1,6-mannosyltransferase" GeneID="85365" HGNC_ID="HGNC:23159" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="99216425" stop="99221942" display_start="99216425" display_stop="99221942" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="101978706" stop="101984245" display_start="101978706" display_stop="101984245" Strand="-" />
          </Location>
          <OMIM>607905</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033087.4(ALG2):c.1040del (p.Gly347fs)</Name>
      <CanonicalSPDI>NC_000009.12:99218144:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="99218145" stop="99218145" display_start="99218145" display_stop="99218145" variantLength="1" positionVCF="99218144" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="101980427" stop="101980427" display_start="101980427" display_stop="101980427" variantLength="1" positionVCF="101980426" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G347fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.101980429del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.101980429del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.99218147del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.99218147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008928.1" sequenceAccession="NG_008928" sequenceVersion="1" change="g.8820del">
            <Expression>NG_008928.1:g.8820del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033087.4" sequenceAccession="NM_033087" sequenceVersion="4" change="c.1040del" MANESelect="true">
            <Expression>NM_033087.4:c.1040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_149078.1" sequenceAccession="NP_149078" sequenceVersion="1" change="p.Gly347fs">
            <Expression>NP_149078.1:p.Gly347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_024532.2" sequenceAccession="NR_024532" sequenceVersion="2" change="n.1247del">
            <Expression>NR_024532.2:n.1247del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252406" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607905.0001" DB="OMIM" />
        <XRef Type="rs" ID="387906281" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033087.4(ALG2):c.1040del (p.Gly347fs) AND multiple conditions" Accession="RCV001060196" Version="15">
        <ClassifiedConditionList TraitSetID="35292">
          <ClassifiedCondition DB="MedGen" ID="C1842836">ALG2-congenital disorder of glycosylation</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4015597">Congenital myasthenic syndrome 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-20" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033087.4(ALG2):c.1040del (p.Gly347fs) AND ALG2-congenital disorder of glycosylation" Accession="RCV004562184" Version="1">
        <ClassifiedConditionList TraitSetID="689">
          <ClassifiedCondition DB="MedGen" ID="C1842836">ALG2-congenital disorder of glycosylation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033087.4(ALG2):c.1040del (p.Gly347fs) AND not provided" Accession="RCV004589494" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-20" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-20" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-02-24" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12684507</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="35292" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32735" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myasthenic syndrome, congenital, 14, with tubular aggregates</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome 14</ElementValue>
                <XRef ID="MONDO:0014543" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMS14</ElementValue>
                <XRef Type="MIM" ID="616228" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMSTA3</ElementValue>
                <XRef Type="MIM" ID="616228" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18454" />
                <XRef ID="18454" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="353327" DB="Orphanet" />
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C4015597" DB="MedGen" />
              <XRef ID="MONDO:0014543" DB="MONDO" />
              <XRef Type="MIM" ID="616228" DB="OMIM" />
            </Trait>
            <Trait ID="1002" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607905.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG 1I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carbohydrate-deficient glycoprotein syndrome type 1I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALG2-CDG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital disorder of glycosylation type 1I</ElementValue>
                <XRef ID="Congenital+Disorder+of+Glycosylation+Type+1I/1814" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">ALG2-congenital disorder of glycosylation</ElementValue>
                <XRef ID="MONDO:0011933" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG Ii</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CDG1I</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CDGIi</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9836" />
                <XRef ID="9836" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301507</ID>
                <ID Source="BookShelf">NBK1332</ID>
              </Citation>
              <XRef ID="79326" DB="Orphanet" />
              <XRef ID="C1842836" DB="MedGen" />
              <XRef ID="MONDO:0011933" DB="MONDO" />
              <XRef Type="MIM" ID="607906" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="689" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1002" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607905.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG 1I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carbohydrate-deficient glycoprotein syndrome type 1I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALG2-CDG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital disorder of glycosylation type 1I</ElementValue>
                <XRef ID="Congenital+Disorder+of+Glycosylation+Type+1I/1814" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">ALG2-congenital disorder of glycosylation</ElementValue>
                <XRef ID="MONDO:0011933" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG Ii</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CDG1I</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CDGIi</ElementValue>
                <XRef Type="MIM" ID="607906" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9836" />
                <XRef ID="9836" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301507</ID>
                <ID Source="BookShelf">NBK1332</ID>
              </Citation>
              <XRef ID="79326" DB="Orphanet" />
              <XRef ID="C1842836" DB="MedGen" />
              <XRef ID="MONDO:0011933" DB="MONDO" />
              <XRef Type="MIM" ID="607906" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22976" SubmissionDate="2022-04-05" DateLastUpdated="2022-04-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607905.0001_CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii" title="ALG2, 1-BP DEL, 1040G_CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii" />
        <ClinVarAccession Accession="SCV000022976" DateUpdated="2022-04-12" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-06-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with congenital disorder of glycosylation type Ii (CDG1I; 607906), Thiel et al. (2003) identified compound heterozygosity for 2 mutations in the ALG2 gene. One mutation was a 1-bp deletion (G) at nucleotide 1040, and the other was a G-to-T transversion at nucleotide 393 (607905.0002). The deletion of 1040G caused a frameshift that altered the sequence after amino acid 346 and led to a premature translation stop at amino acid 372. At the level of RNA, the patient was homozygous for this mutation, indicating that the transcript carrying the 393G-T substitution was unstable. The patient's mother was heterozygous for the 1040G deletion. The father was heterozygous for the 393G-T substitution, and no transcripts with the 393G-T substitution were detected in him.</Attribute>
              <Citation>
                <ID Source="PubMed">12684507</ID>
              </Citation>
              <XRef DB="OMIM" ID="607906" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALG2" />
          </GeneList>
          <Name>ALG2, 1-BP DEL, 1040G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1040G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607905.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2390367" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="1182225|MedGen:C1842836;C4015597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001224872" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12684507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12684507</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 2699). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this premature translational stop signal affects ALG2 function (PMID: 12684507). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This premature translational stop signal has been observed in individuals with ALG2-related disease (PMID: 12684507; Invitae). This variant is present in population databases (rs387906281, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gly347Valfs*27) in the ALG2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 70 amino acid(s) of the ALG2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALG2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.101980427del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1842836" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4015597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9861785" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="GDXSV:479542" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005080453" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect, as the variant is a null allele that results in significantly reduced expression (Ehrstedt et al., 2022); Frameshift variant predicted to result in protein truncation as the last 70 amino acids are replaced with 26 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 12684507, 34980536)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALG2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:743348</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033087.3:c.1040del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9861785" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22976" TraitType="Disease" MappingType="Name" MappingValue="CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii" MappingRef="Preferred">
        <MedGen CUI="C5574948" Name="Congenital disorder of glycosylation type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2390367" TraitType="Disease" MappingType="XRef" MappingValue="C4015597" MappingRef="MedGen">
        <MedGen CUI="C4015597" Name="Congenital myasthenic syndrome 14" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2390367" TraitType="Disease" MappingType="XRef" MappingValue="C1842836" MappingRef="MedGen">
        <MedGen CUI="C1842836" Name="ALG2-congenital disorder of glycosylation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

